Clinical Trial Update: Dendritic Cell Vaccine for Patients With Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial of an autologous dendritic cell vaccine for brain tumors has completed enrollment and assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma
• Glioma

Drugs mentioned

• Autologous dendritic cell vaccine (dendritic cell vaccine)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Glioma, Anaplastic Astrocytoma | Phase 2 | Status: COMPLETED